Jason Freeman

Mar 15, 2024 | neurologylive.com | Jason Freeman

WATCH TIME: 3 minutes“Sometimes there's pushback in the community to say that [ofatumumab] worked in a clinical trial but let's see what happens when you get to patients who are just out there in the community.

Jan 15, 2024 | cancernetwork.com | Jason Freeman

Including more male patients with breast cancer in clinical trials may help to accrue more data on survival disparities in this population, said Jason (Jincong) Q. Freeman, MPH, MS, in a conversation with CancerNetwork®.

Dec 6, 2023 | onclive.com | Jason Freeman

December 6, 2023Jason Jincong Freeman, PhD, discusses mortality differences across various racial groups in male patients with stage I, II, or III breast cancer.

Oct 30, 2023 | neurologylive.com | Jason Freeman |Hunter Davis

October 30, 2023OpinionVideoSponsored By NovartisJason Freeman, MD, MBA, and Hunter Davis, PharmD, discuss the poster “Patient Reported Outcomes and Clinical Disability Outcomes in MS demonstrate the same rates of worsening when performed in neurology clinic, patient registry, and a clinical trial” presented at AAN 2023. Sponsored By Novartis. Jason Freeman, MD, MBA: Welcome to AAN 2023.

Aug 23, 2023 | neurologylive.com | Jason Freeman |Arsalan Syed

Disease SpotlightFellows' CornerFuture Leaders in NeurologyGiants of Multiple SclerosisInteractive ToolsLive EventsNeurology ResourcesSponsoredVirtual Events